• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化应激在终末期肾病红细胞生成素低反应性贫血中的作用:分子和生化研究。

Oxidative stress during erythropoietin hyporesponsiveness anemia at end stage renal disease: Molecular and biochemical studies.

机构信息

Department of Biochemistry and Chemistry of Nutrition, Faculty of Veterinary Medicine, Cairo University, 12211 Giza, Egypt; Department of Clinical Chemistry, Maadi Armed Forces Hospital, Cairo, Egypt.

Department of Biochemistry and Chemistry of Nutrition, Faculty of Veterinary Medicine, Cairo University, 12211 Giza, Egypt.

出版信息

J Adv Res. 2016 May;7(3):348-58. doi: 10.1016/j.jare.2016.02.004. Epub 2016 Feb 23.

DOI:10.1016/j.jare.2016.02.004
PMID:27222740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4856826/
Abstract

Inflammation and oxidative stress are two faces of one coin in end stage renal disease patients (ESRD) on maintenance hemodialysis. Their interconnection induces anemia complicated with erythropoietin hyporesponsiveness. The biochemical bases behind the resistance to erythropoietin therapy with frequent hemoglobinemia, oxidative stress and iron status have not been fully understood. Here two equal groups (40 patients each) of responders and non-responders to recombinant human erythropoietin therapy (higher than 300 IU/kg/wk of epoetin) were investigated. Hematological and biochemical analyses of collected blood and serum samples were performed along with serum electrophoretic protein footprinting. The leukocytic DNA fragmentation was used to evaluate the degree of oxidative insult. The good responders showed lower erythrocyte malondialdehyde (E-MDA) level and less DNA fragmentation of circulating leukocytes than poor responders with elevated hemoglobin, albumin, A/G ratio, total iron, and ferritin levels. Contrariwise, lower erythrocyte superoxide dismutase (E-SOD) and catalase activities in EPO poor responder group were noticed. Neither other serum constituents nor electrophoretic protein pattern showed any difference between the two groups. There were higher levels of inflammatory markers, interleukin-6 (IL6) and C-reactive protein (CRP) in EPO poor responder than good responder. The negative correlations between Hb and both IL6 and CRP levels in the present data remotely indicate a positive correlation between inflammatory markers and severity of anemia. A direct correlation between Hb and antioxidant enzymes (E-SOD and catalase) was noticed, while inverse correlation with E-MDA was recorded. The study proved that oral supplementation of vitamin C to ESRD patients might mitigate the previously elevated serum MDA level in these patients.

摘要

在接受维持性血液透析的终末期肾病(ESRD)患者中,炎症和氧化应激是同一硬币的两面。它们的相互作用导致贫血合并红细胞生成素反应低下。频繁的血红蛋白血症、氧化应激和铁状态导致对红细胞生成素治疗产生抵抗的生化基础尚未完全理解。在这里,我们调查了对重组人红细胞生成素治疗(高于 300 IU/kg/wk 的促红素)有反应和无反应的两组(每组 40 例)患者。对采集的血液和血清样本进行了血液学和生化分析,并进行了血清电泳蛋白足迹分析。白细胞 DNA 片段化用于评估氧化损伤程度。与血红蛋白、白蛋白、A/G 比值、总铁和铁蛋白水平升高的不良反应者相比,良好反应者的红细胞丙二醛(E-MDA)水平较低,循环白细胞的 DNA 片段化程度较低。相反,在 EPO 反应不良者中,红细胞超氧化物歧化酶(E-SOD)和过氧化氢酶活性较低。两组之间的其他血清成分或电泳蛋白图谱均无差异。EPO 反应不良者的炎症标志物白细胞介素-6(IL6)和 C 反应蛋白(CRP)水平较高。本研究数据中 Hb 与 IL6 和 CRP 水平之间的负相关表明,炎症标志物与贫血严重程度之间存在正相关。Hb 与抗氧化酶(E-SOD 和过氧化氢酶)之间存在直接相关性,而与 E-MDA 呈负相关。该研究证明,向 ESRD 患者口服补充维生素 C 可能会减轻这些患者先前升高的血清 MDA 水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598b/4856826/302a6b960c7c/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598b/4856826/302a6b960c7c/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/598b/4856826/302a6b960c7c/fx2.jpg

相似文献

1
Oxidative stress during erythropoietin hyporesponsiveness anemia at end stage renal disease: Molecular and biochemical studies.氧化应激在终末期肾病红细胞生成素低反应性贫血中的作用:分子和生化研究。
J Adv Res. 2016 May;7(3):348-58. doi: 10.1016/j.jare.2016.02.004. Epub 2016 Feb 23.
2
Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.静脉注射维生素C对伴有促红细胞生成素低反应性贫血和高铁蛋白血症的血液透析患者的影响。
Am J Kidney Dis. 2006 Apr;47(4):644-54. doi: 10.1053/j.ajkd.2005.12.025.
3
Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis?非酒精性脂肪性肝病(NAFLD)——它是慢性血液透析患者对重组人促红细胞生成素低反应性的新标志物吗?
Med Hypotheses. 2014 Dec;83(6):798-801. doi: 10.1016/j.mehy.2014.10.012. Epub 2014 Oct 22.
4
Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients.营养不良-炎症复合综合征对维持性血液透析患者促红细胞生成素低反应性的影响。
Am J Kidney Dis. 2003 Oct;42(4):761-73. doi: 10.1016/s0272-6386(03)00915-6.
5
Evaluation of Effect of Vitamin D Deficiency on Anemia and Erythropoietin Hyporesponsiveness in Patients of Chronic Kidney Disease.维生素D缺乏对慢性肾脏病患者贫血及促红细胞生成素低反应性的影响评估
J Assoc Physicians India. 2017 Feb;65(2):38-42.
6
Antioxidant status and lipid peroxidation in hemodialysis patients undergoing erythropoietin and erythropoietin-vitamin E combined therapy.接受促红细胞生成素和促红细胞生成素 - 维生素E联合治疗的血液透析患者的抗氧化状态和脂质过氧化
Free Radic Res. 1999 Sep;31(3):211-6. doi: 10.1080/10715769900300771.
7
Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.血液透析患者红细胞膜脂质过氧化与促红细胞生成素治疗抵抗
Clin Nephrol. 1999 Oct;52(4):239-45.
8
Serum hepcidin levels in patients with end-stage renal disease on hemodialysis.接受血液透析的终末期肾病患者的血清铁调素水平
Saudi J Kidney Dis Transpl. 2015 Jan;26(1):19-25. doi: 10.4103/1319-2442.148716.
9
Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.口服十全大补汤/TJ - 48可改善血液透析患者对促红细胞生成素(rHuEPO)抵抗性贫血的症状。
Hemodial Int. 2008 Oct;12 Suppl 2:S9-S14. doi: 10.1111/j.1542-4758.2008.00317.x.
10
2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.2008年日本透析治疗学会:慢性肾脏病肾性贫血指南
Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.

引用本文的文献

1
Intersecting Pathways of Inflammation, Oxidative Stress, and Atherogenesis in the Evaluation of CKD: Emerging Biomarkers PCSK9, EPHX2, AOPPs, and TBARSs.慢性肾脏病评估中炎症、氧化应激与动脉粥样硬化发生的交叉途径:新兴生物标志物前蛋白转化酶枯草溶菌素9、环氧化物水解酶2、晚期氧化蛋白产物及硫代巴比妥酸反应物
Life (Basel). 2025 Aug 13;15(8):1287. doi: 10.3390/life15081287.
2
Erythropoietin Resistance Development in Hemodialysis Patients: The Role of Oxidative Stress.血液透析患者红细胞生成素抵抗的发生机制:氧化应激的作用。
Oxid Med Cell Longev. 2022 Apr 14;2022:9598211. doi: 10.1155/2022/9598211. eCollection 2022.
3
Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: "Can the Promise Be Kept?".

本文引用的文献

1
Evaluation of lipid peroxidation and erythrocyte glutathione peroxidase and superoxide dismutase in hemodialysis patients.血液透析患者脂质过氧化、红细胞谷胱甘肽过氧化物酶和超氧化物歧化酶的评估
Saudi J Kidney Dis Transpl. 2012 Mar;23(2):274-9.
2
IL-6 is an independent risk factor for resistance to erythropoiesis-stimulating agents in hemodialysis patients without iron deficiency.白细胞介素-6是无缺铁情况的血液透析患者对促红细胞生成素产生抵抗的独立危险因素。
Hemodial Int. 2012 Jan;16(1):31-7. doi: 10.1111/j.1542-4758.2011.00635.x.
3
The relationships between exogenous and endogenous antioxidants with the lipid profile and oxidative damage in hemodialysis patients.
缺氧诱导因子稳定剂在终末期肾病中的应用:“承诺能否兑现?”。
Int J Mol Sci. 2021 Nov 22;22(22):12590. doi: 10.3390/ijms222212590.
4
Oxidative Stress Parameters Can Predict the Response to Erythropoiesis-Stimulating Agents in Myelodysplastic Syndrome Patients.氧化应激参数可预测骨髓增生异常综合征患者对促红细胞生成素的反应。
Front Cell Dev Biol. 2021 Jun 7;9:701328. doi: 10.3389/fcell.2021.701328. eCollection 2021.
5
A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat.治疗慢性肾脏病炎症诱导性贫血的新选择:口服低氧诱导因子脯氨酰羟化酶抑制剂罗沙司他。
Front Med (Lausanne). 2020 Aug 6;7:393. doi: 10.3389/fmed.2020.00393. eCollection 2020.
6
Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease.慢性肾脏病作为氧化应激和炎症介导的心血管疾病
Antioxidants (Basel). 2020 Aug 14;9(8):752. doi: 10.3390/antiox9080752.
7
Successful treatment of anti-EPO antibody associated refractory anemia with hypoxia-inducible factor prolyl hydroxylase inhibitor.用缺氧诱导因子脯氨酰羟化酶抑制剂成功治疗抗促红细胞生成素抗体相关难治性贫血。
Ren Fail. 2020 Nov;42(1):860-864. doi: 10.1080/0886022X.2020.1803087.
8
Erythropoietin suppresses D-galactose-induced aging of rats via the PI3K/Akt/Nrf2-ARE pathway.促红细胞生成素通过PI3K/Akt/Nrf2-ARE途径抑制D-半乳糖诱导的大鼠衰老。
Int J Clin Exp Pathol. 2018 Apr 1;11(4):2227-2240. eCollection 2018.
9
Siwu Granules and Erythropoietin Synergistically Ameliorated Anemia in Adenine-Induced Chronic Renal Failure Rats.四物汤颗粒与促红细胞生成素协同改善腺嘌呤诱导的慢性肾衰竭大鼠贫血
Evid Based Complement Alternat Med. 2019 Dec 14;2019:5832105. doi: 10.1155/2019/5832105. eCollection 2019.
10
Uremic leontiasis ossea due to secondary hyperparathyroidism complicated by vitamin C deficiency in a non-adherent chronic hemodialysis patient: A case report.一名不依从治疗的慢性血液透析患者因继发性甲状旁腺功能亢进并发维生素C缺乏导致的尿毒症性骨性狮面:病例报告
Clin Nephrol Case Stud. 2019 Sep 9;7:54-59. doi: 10.5414/CNCS109788. eCollection 2019.
血液透析患者中外源性和内源性抗氧化剂与血脂谱和氧化损伤的关系。
BMC Nephrol. 2011 Oct 26;12:59. doi: 10.1186/1471-2369-12-59.
4
Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study.贫血和对红细胞生成刺激剂的抵抗作为血液透析患者的预后因素:来自 RISCAVID 研究的结果。
Nephrol Dial Transplant. 2011 Aug;26(8):2641-8. doi: 10.1093/ndt/gfq802. Epub 2011 Feb 16.
5
Erythropoietic response and outcomes in kidney disease and type 2 diabetes.肾脏疾病和 2 型糖尿病患者的红细胞生成反应和结局。
N Engl J Med. 2010 Sep 16;363(12):1146-55. doi: 10.1056/NEJMoa1005109.
6
The effect of selenium supplementation in the prevention of DNA damage in white blood cells of hemodialyzed patients: a pilot study.硒补充剂对血液透析患者白细胞 DNA 损伤预防作用的初步研究。
Biol Trace Elem Res. 2011 Sep;142(3):274-83. doi: 10.1007/s12011-010-8776-0. Epub 2010 Jul 27.
7
Effects of hemodialysis period on levels of blood trace elements and oxidative stress.血液微量元素和氧化应激与血液透析时间的关系。
Clin Exp Nephrol. 2010 Oct;14(5):463-8. doi: 10.1007/s10157-010-0310-3. Epub 2010 Jun 30.
8
Serum albumin fragmentation in end-stage renal disease patients--a pilot study.终末期肾病患者血清白蛋白碎片化:一项初步研究。
Clin Chem Lab Med. 2009;47(11):1373-9. doi: 10.1515/CCLM.2009.303.
9
Associations of anemia persistency with medical expenditures in Medicare ESRD patients on dialysis.透析的 Medicare ESRD 患者中贫血持续性与医疗支出的关联。
Ther Clin Risk Manag. 2009 Aug;5(4):319-30. doi: 10.2147/tcrm.s4856. Epub 2009 May 4.
10
Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.慢性血液透析患者血清铁调素浓度:透析、铁和红细胞生成素治疗的关联和影响。
Eur J Clin Invest. 2009 Oct;39(10):883-90. doi: 10.1111/j.1365-2362.2009.02182.x. Epub 2009 Jun 26.